Refractory anemia with excess blasts

Synonyms: RAEB

Refractory anemia with excess blasts (RAEB) is a frequent severe subtype of myelodysplastic syndrome (MDS; see this term) characterized by cytopenias with unilineage or multilineage dysplasia and 5% to 19% blasts in bone marrow or blood.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2026

Newly diagnosed with
Refractory anemia with excess blasts?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Clinical Trials

For a list of clinical trials in this disease area, please click here.

Refractory anemia with excess blasts

Get in touch with RARE Concierge.

Newly diagnosed with Refractory anemia with excess blasts?

Related Content

Gilead To Discontinue Phase 3 Study of Magrolimab Plus Azacitidine in Higher-Risk MDS

FDA Expands Approval of Servier’s Therapy for Rare Form of Blood Cancers

The Lancet Publishes Geron’s Phase 3 Results in Lower Risk MDS

FDA Awards Keros Fast Track Designation for Experimental Therapy to Treat MDS

FDA Grants RMAT Designation to TScan’s Two Lead TCR-T Candidates for Blood Cancers

FDA Approves Geron’s Rytelo for Adults with Rare Blood Cancer

FDA Approves Gamida Cell’s Allogeneic Cell Therapy Omisirge for Hematological Malignancies

Clinical Trials

Newly diagnosed with
Refractory anemia with excess blasts?